Navigation Links
Brand Name Drug Prices Zoom

A report has found that prices of 200 brand name drugs which are taken regularly by older Americans have risen by 6.3% during the 12 month period ending // mid June 2006, against an inflation rate of 3.8%. The survey was conducted by AARP and reported in their Rx Watchdog Report released on Tuesday. It is also reported that the prices of 75 commonly used generic drugs remain the same.

Heading the list of drugs with highest price rise is Aventis' Ambien 5mg with a hike of 13.3%.It is followed by Boehringer Ingelheim's Combivent (12%), Pfizer's Atrovent (12%), Ambien 10mg (9.9%) and Glaxo Smith Kline's Wellbutin (9.4%).

The biggest average six month price rise has been reported in Aventis, up by 7.7% and the lowest in Monarch and Takeda (0%) and Lilly (2.5%).

The report author Susan Raetzman, assosiate director of AARP's Public Policy Institute said that though the rate of price increase is the same as in recent years, it means an increase of over $70 annually, for a drug which is taken regularly. Considering an average annual cost of $300 on drugs for older people, this is quite steep.

Raetzman said that this would also affect people on Medicare Plan D as the cost increases get passed on to its members.

To help contain the drug price hikes AARP is supporting a bill in Congress, which will permit the import of drugs from Canada and other western countries.

David Sloane, AARP's senior managing director of government relations said in a prepared statement that for the first time a bill of this nature has received widespread support .It would allow safe and legal import of drugs.

The executive director, Sharon Treat of the National Legislative Association on Prescription Drug Prices, a nonpartisan, nonprofit group founded by state legislators to make prescription drugs more affordable and accessible to Americans, said that the price increases are unjustified.

She felt that the people and the government were being ripped off and added that the Medicare Plan D seems to have spurred on the price increase. Under this plan the federal government cannot negotiate the prices of the drugs, which has resulted in a situation where reduction in the prices is not a priority.
'"/>




Related medicine news :

1. Variations In ingredients From Brand to Brand
2. Drinking Brandy Is Good For Health
3. Marketing of Low Tar Cigarette Brand by BAT Unethical
4. New Research Reveals How We Process Brands And Products
5. Big Brands Ensure Lasting Influences In Dietary Choices.
6. Brain Responds Better to Name Brands
7. Salmonella Contamination Suspected In A Brand Of Fresh Spinach
8. Some Brands of Ready Meals Recalled After Glass Scare
9. Two Brands of Pesto Recalled in Quebec, Ontario
10. Drug Companies May Be Penalize For Overcharging NHS Tax Payers Money on Branded Drugs
11. Ark Land Brand Bottled Water Faces a Bottleneck
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 13, 2017 , ... As health professionals work to improve their approach to ... is doing more than filling out a survey; in many cases health professionals and ... in health care and research on the importance of active engagement with patients and ...
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family ... next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. ... 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health ... technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing ... form that can be easily incorporated into liquid products, while reducing costs to end ...
(Date:10/13/2017)... QUEENS, N.Y (PRWEB) , ... October 13, 2017 , ... ... recently became a member of ElderCounsel, a national organization of elder law and special ... constantly changing laws and rules. It also provides a forum to network with elder ...
(Date:10/13/2017)... OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... or dementia. However, many long-term care insurance companies have a waiver for care if ... the 90-day elimination period, when the family pays for care, is often waived, so ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017  Eli Lilly and Company (NYSE: ... the third quarter of 2017 on Tuesday, October 24, ... that day with the investment community and media to ... conference call will begin at 9 a.m. Eastern time. ... live webcast of the conference call through a link ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology: